Home › Schizophrenia › Arkansas
Schizophrenia clinical trials in Arkansas
21 studies for Schizophrenia are looking for participants at sites in Arkansas.
Cities in Arkansas
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Pillar Clinical Research - Bentonville, Bentonville
- Pillar Clinical Research- Little Rock, Little Rock
- Local Institution - 0021, Little Rock
- and 1 more
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 28, 2026 · NCT07686263NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Bryant
- Neurocrine Clinical Site, Little Rock
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 25, 2026 · NCT07114874Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Pillar Clinical Research, LLC, Little Rock
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 25, 2026 · NCT06229210NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Little Rock
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 25, 2026 · NCT07105098Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
- TG Therapeutics Investigational Trial Site, Little Rock
RecruitingPhase 2
Ages 18 to 60 · All sexes · Updated Sep 23, 2026 · NCT07680946A Study of Brenipatide in Adult Participants With Schizophrenia
- Pillar Clinical Research- Little Rock, Little Rock
RecruitingPhase 2
Ages 18 to 55 · All sexes · Updated Sep 22, 2026 · NCT07410507A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Bryant
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07105111A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- Pillar Clinical Research, LLC, Little Rock
RecruitingPhase 1
Ages 18 to 55 · All sexes · Updated Sep 17, 2026 · NCT07734493A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
- Woodland International Research Group /ID# 275747, Little Rock
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 15, 2026 · NCT0714591852-week Open Label Safety-Tolerability Study
- Pillar Clinical Research, Bentonville
- Pillar Clinical Research, Little Rock
- Woodland International Research Group, Little Rock
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 9, 2026 · NCT07369154A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Little Rock
- Clinical Site, Little Rock
- Clinical Site, Rogers
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 1, 2026 · NCT07459647Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- SanRo Clinical Research Group, Bryant
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT07379827Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Alkermes Investigator Site, Little Rock
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Aug 14, 2026 · NCT05303064Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
- Pillar Clinical Research LLC, Bentonville
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Jul 29, 2026 · NCT07467993Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
- Pillar Clinical Research, Bentonville
- Pillar Clinical Research, Little Rock
- Woodland International Research Group, Little Rock
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jul 27, 2026 · NCT07363577A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- Woodland International Research Group, Little Rock
RecruitingPhase 2
Ages 18 to 55 · All sexes · Updated Jun 23, 2026 · NCT07191483A Study to Evaluate the Effect of KarXT on Urological Safety
- Pillar Clinical Research- Little Rock, Little Rock
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Jun 3, 2026 · NCT07221877NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Bryant
- Neurocrine Clinical Site, Little Rock
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Mar 6, 2026 · NCT06963034Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, Rogers
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jan 12, 2026 · NCT06961968Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
- Vanda Investigational Site, Little Rock
RecruitingPhase 4
Ages 12 to 17 · All sexes · Updated Mar 4, 2025 · NCT05648591Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- Reviva site, Bentonville
- Reviva site, Little Rock
- Reviva site, Rogers
RecruitingPhase 3Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Dec 19, 2024 · NCT05184335From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.